Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its product candidate includes RP-G28.
Website: | www.ritterpharmaceuticals.com |
Main Phone: | +1 310 203-1000 |
Address: | 1880 Century Park East |
Address 2: | Suite 1000 |
State: | CA |
City / Town: | Los Angeles |
Country: | USA |
Postal Code: | 90067 |
Exchange: | NSC |
Employees: | 8 |
NAICS: | Pharmaceutical P |
Last Price 3.17 | Change $ -0.11 | Change % -3.35 | Tick N/A |
Bid 3.02 | Bid Size 500.00 | Ask 3.60 | Ask Size 5,000.00 |
Open 3.31 | High 3.68 | Low 3.11 | Prev Close 3.28 |
Last Trade | Volume 337,556 | 52 Wk Hi 11.40 | 52 Wk Low 1.83 |
Market Cap 15.7 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares 4,940,652.00 | EPS (TTM) -5.00 | PE Ratio N/A | Exchange NCM |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 0 | 4 |
Number of Buys | 0 | 4 |
Number of Sells | 0 | 0 |
Net Activity | 0 | 52500 |
Last 10 Buys | Shares |
---|---|
Ira E. Ritter | 1,000 |
Andrew J. Ritter | 1,000 |
Matthew W. Foehr | 1,000 |
Michael D. Step | 1,000 |
Noah J. Doyle | 1,000 |
Matthew W. Foehr | 1,000 |
Gerald T. Proehl | 1,000 |
Last 10 Sell | Shares |
---|---|
N/A | 0 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 7 | 7 | 7 | 7 |
Low Target Price Estimate | 3 | 3 | 3 | 3 |
Mean Target Price Estimate | 5.33 | 5.67 | 5.67 | 5.33 |
Standard Deviation | 2.08 | 2.31 | 2.31 | 2.08 |
Date of Most Recent Estimate | 08/15/16 | 06/21/16 | 06/21/16 | 08/23/16 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-08-23 |
S-3 | Simplified registration form | 126 | 2016-08-11 |
10-Q | Quarterly report with a continuing view of a company's financial position | 41 | 2016-08-08 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-07 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-07 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-07 |
S-8 | Securities offered to employees under employee benefit plans | 37 | 2016-06-16 |
EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-06-07 |
8-K | Report of unscheduled material events or corporate changes. | 9 | 2016-06-06 |
POS AM | Post-effective amendment to an S-Type filing | 38 | 2016-06-01 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 1 | 1 | 1 | 1 |